Form D Explorer

Form C/A — Oxeia Biopharmaceuticals, Inc.

0001610315-26-000007 · filed 2026-04-02 · via StartEngine Primary, LLC

Offering

Target: $19,999
Maximum: $4,999,999
Security type: Other
Price per security: $0.7900
Deadline: —
Oversubscription: Accepted

Issuer

Name: Oxeia Biopharmaceuticals, Inc.
CIK: 1610315
Entity: Corporation
Jurisdiction: DE
Address: 361 Newbury Street
Boston, MA 02115
Phone: —

Most recent fiscal year financials

Total assets

$260,456

Cash

—

Short-term debt

$12,676,450

Long-term debt

—

Revenues

—

COGS

—

Taxes paid

—

Net income

$-1,246,701

View original on SEC EDGAR.